Can fasting and a common pill slow breast cancer growth?
NCT ID NCT05023967
Summary
This study is testing if combining time-restricted eating (fasting for at least 16 hours each night) with the diabetes drug metformin can slow the growth of early-stage breast cancer. It involves 120 women who are scheduled for surgery. The goal is to see if this combination reduces cancer cell activity and could become a new way to help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
European Institute of Oncology
Milan, 20141, Italy
-
Galliera Hospital
Genoa, 16128, Italy
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.